Portal de investigación
Modulación de la respuesta al tratamiento anti-HER2 mediante regulación del microentorno tumoral.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO
Resultados del Ensayo Clínico
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer
Lameirinhas, A; (...); Eroles, P
Article. 10.1186/s10020-025-01163-z. 2025
MicroRNAs as a clue to overcome breast cancer treatment resistance.
Garrido-Cano, Iris; (...); Eroles, Pilar
Article. 10.1007/s10555-021-09992-0. 2022
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+Breast Cancer
Cabello, Paula; (...); Eroles, Pilar
Article. 10.3390/cancers15072138. 2023
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer
Torres-Ruiz, S; (...); Eroles, P
Article. 10.1038/s41420-024-02128-7. 2024
